raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:747

Autoimmune pulmonary alveolar proteinosis

Synonyms: Autoimmune PAP · aPAP

Type
Disease
Group
Disorder
Inheritance
Multigenic/multifactorial, Not applicable
Age of onset
Adolescent, Adult, Childhood
Status
active

A rare primary interstitial lung disease characterized by the accumulation of lipids and proteins related to surfactant in the alveoli in association with the presence of antibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF). The disease leads to a progressive impairment of gas exchange and respiratory insufficiency.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAutoimmune pulmonary alveolar proteinosisAutoimmune PAP · aPAP
frProtéinose alvéolaire pulmonaire auto-immunePAP auto-immune · aPAP
dePulmonale Alveolarproteinose, autoimmunePAP, autoimmune · PAP, idiopathische · Pulmonale Alveolarproteinose, idiopathische · aPAP · iPAP
esProteinosis alveolar pulmonar autoinmunePAP autoinmune · PAPa
itProteinosi alveolare polmonare autoimmunePAP autoimmune · aPAP
nlAuto-immune pulmonale alveolaire proteïnoseAuto-immune PAP · aPAP
ptProteinose alveolar pulmonar autoimunePAP autoimune
plAutoimmunologiczna proteinoza pęcherzyków płucnychaPAP · Autoimmunologiczna PAP · Idiopatyczna PAP · Idiopatyczna proteinoza pęcherzyków płucnych · iPAP
csAutoimunitní plicní alveolární proteinózaAutoimunitní PAP · Idiopatická PAP · Idiopatická plicní alveolární proteinóza · aPAP · iPAP
ukАутоімунний альвеолярний протеїноз легеньaPAP · Аутоімунний PAP
zh自身免疫性肺泡蛋白沉积症特发性肺泡蛋白沉积症
trOtoimmün pulmoner alveolar proteinozaPAP · iPAP · Otoimmün PAP · İdiyopatik PAP · İdiyopatik pulmoner alveolar proteinoz

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM610910Evalidated
ICD-10J84.0NTBTinclusionvalidated
ICD-11CB04.31NTBTindexvalidated
MONDO0012579Evalidated
UMLSC1970472Evalidated
GARD7499Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
HLA-DRB1Major susceptibility factor inAssessedHGNC:4948ENSG000001961261428576p21.32major histocompatibility complex, class II, DR beta 133589587[PMID]
5

Prevalence and incidence

4 records
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 1 000 0000.165 / 100 000JapanValue and classValidated30895185[PMID]
Point prevalence1-9 / 1 000 0002.66 / 100 000JapanValue and classValidated30895185[PMID]
Point prevalence1-9 / 1 000 0002.66 / 100 000WorldwideValue and classValidated30895185[PMID]_30064481[PMID]
Point prevalence1-9 / 1 000 0000.687 / 100 000United StatesValue and classValidated30064481[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

20 annotations · validated 2017-10-23
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0006517Intraalveolar phospholipid accumulation
Frequent (79-30%)
HP:0010876Abnormal circulating protein level
HP:0002087Abnormality of the upper respiratory tract
HP:0030057Autoimmune antibody positivity
HP:0001217Clubbing
HP:0000961Cyanosis
HP:0045051Decreased DLCO
HP:0002094Dyspnea
HP:0003651Foam cells
HP:0012418Hypoxemia
HP:0025435Increased circulating lactate dehydrogenase concentration
HP:0002091Restrictive ventilatory defect
Occasional (29-5%)
HP:0012735Cough
HP:0030830Crackles
HP:0025391Crazy paving pattern on pulmonary HRCT
Very rare (<4-1%)
HP:0100749Chest pain
HP:0012378Fatigue
HP:0001945Fever
HP:0002105Hemoptysis
HP:0001824Weight loss

Run the differential on the 1 obligate / very frequent terms

Annotation source: 21632797[PMID]

7

Sources for this card